About Curium Pharma
Curium Pharma is a Healthcare company based in Paris (France) founded in 2017. Curium Pharma is recognized as a leader in radiopharmaceuticals. It operates on a Direct-to-Consumer (D2C), Professional Services, and HealthTech model. Curium Pharma has completed 4 acquisitions, including Cyclopharma, Monrol and NUCLEIS. Its chief executive, as recorded, is Renaud Dehareng. Its website curiumpharma.com draws about 22 thousand monthly visits. Curium Pharma offers products and services including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products. Its focus areas include Pharmaceuticals and Radiopharmaceuticals. Its legal entity is Curium Bidco sarl.
Company details
Curium Pharma is established as a global leader in the field of nuclear medicine, specializing in radiopharmaceuticals. The company is focused on the development and supply of innovative products used for the diagnosis and treatment of various diseases. Operations are conducted across multiple sectors within healthcare, with solutions provided to over 35,000 patients daily. A diverse portfolio including generators, cold kits, and hot products is maintained, ensuring high-quality care through a network spanning over 70 countries. Commitment to safety and reliability is emphasized in every aspect of production and delivery.
- Headquarters Paris, France
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website curiumpharma.com
- Social LinkedIn X Instagram YouTube
- Legal Name Curium Bidco Sarl
- Investors
- Investments & AcquisitionsCyclopharma
& 3 more
Products & Services of Curium Pharma
Curium Pharma offers a comprehensive portfolio of products and services, including Radiopharmaceuticals, Generators, Cold Kits, and Hot Products.
Radiopharmaceuticals are developed for diagnosis and treatment purposes.
Generators are provided for nuclear medicine diagnostic applications.
Cold kits are supplied for radiopharmaceutical preparation processes.
Hot products are offered for immediate medical use.
Apps and channels of Curium Pharma
its YouTube channel Curium has 644 subscribers and 30 videos.
Videos from Curium Pharma
The most watched videos on Curium Pharma's YouTube channel, Curium (644 subscribers). Click a video to play it here.
More on Curium.
Funding Insights of Curium Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Curium Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2017 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in Curium Pharma
Curium Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CapVest.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
CapVest is recognized as a leading private equity investor. | 1999 | capvest.com | London, United Kingdom |
Investor details for Curium Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Curium Pharma
263 people are tracked at Curium Pharma (106 in leadership, 157 in team).
| Name | Role | Group |
|---|---|---|
Renaud Dehareng | CEO | Leadership |
Kevin White | Director Site Operations | Leadership |
Laïla Boumargoud | Vice President Operations - PET Europe | Leadership |
Veronica Tayson | Director Of Quality And Regulatory Affairs | Leadership |
Bruno Moriceau | Deputy Chief Pharmaceutical Officer (pharmacien Responsable Intérimaire) - Curium PET France | Leadership |
Fred Gattas | Sr. Director Of Global Medical Affairs | Leadership |
Diana Felts | Executive Assistant And Contracts Administration, Office Of The CEO - North America | Leadership |
Nicola Barni | General Manager Italy & Austria And Managing Director At Curium Pharma Italy | Leadership |
Francisco Servia Dopazo | Qualified Person-director Técnico Farmacéutico | Leadership |
Carl Powell | Group Chief Information Officer | Leadership |
Brett Ramsey | Director Clinical Operations | Leadership |
Ruairi Donnell | General Manager UK & Ireland | Leadership |
Daniel Pascal | Marketing Director Europe - Spect International | Leadership |
Kristien Rasschaert | Senior Sales Director Benelux | Leadership |
Paolo Giorgio Lomonaco | PET France Operations Director | Leadership |
Timothee de Courlon | Vice President Strategy - Europe | Leadership |
Hugues Crepin | Group Chief Technology Officer | Leadership |
Chris Brozey | Director Of Strategic Accounts | Leadership |
Michael Gruen | Senior Director, People - North America | Leadership |
Koos Rijnberg | Director Of Manufacturing | Leadership |
243 more people are available in the full profile.
Complete people profiles for Curium Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Curium Pharma
Curium Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cyclopharma, Monrol and NUCLEIS.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
PET radio-pharmaceutical drugs are manufactured under contract. | nucleis.eu | Liege, Belgium | 2017 | Apr 2025 | •••• | |
Manufacturer of radiopharmaceuticals and related products | monrol.com | Kuwait | 1995 | Mar 2025 | •••• | |
Radiolabeling & radiopharmaceutical manufacturing services for nuclear medicine and molecular imaging | zevacor.com | Dulles, United States | 2013 | Mar 2020 | •••• | |
Radiopharmaceuticals for molecular imaging are developed and manufactured. | cyclopharma.fr | Gerzat, France | 2000 | Apr 2018 | •••• |
Complete acquisition details for Curium Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Curium Pharma
6 dated milestones of Curium Pharma across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Curium Pharma is founded.
- Funding First funding round.
- Acquisition Acquires Cyclopharma.
- Acquisition Acquires Zevacor.
- Acquisition Acquires Monrol.
- Acquisition Acquires NUCLEIS.
Web traffic of Curium Pharma
The website of Curium Pharma (curiumpharma.com) receives about 21.6K visits a month and ranks #1,076,746 among all websites worldwide, #1,332 in Biotechnology and Pharmaceuticals.
- Monthly visits21.6K
▼ 7.7% vs previous month
- Unique visitors9.8K
per month
- Global rank#1,076,746
among all websites
- Category rank#1,332
Health · Biotechnology and Pharmaceuticals
- Bounce rate43%
- Pages per visit2.6
- Average visit24 sec
- DevicesDesktop 39% · Mobile 61%
Websites whose visitors overlap most with Curium Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
imedi.co.uk | imedi.co.uk | 100% | #1,749,783 | – | |
urotoday.com | urotoday.com | 100% | #260,951 | – | |
tech.snmjournals.org | tech.snmjournals.org | 100% | #691,971 | – | |
| iba-radiopharmasolutions.com | 100% | #3,532,970 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Curium Pharma
Complete news archive for Curium Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Curium Pharma
Curium Pharma was founded in 2017.
Curium Pharma is headquartered in Paris, France.
Renaud Dehareng is the CEO of Curium Pharma, as recorded in our data.
Curium Pharma is established as a global leader in the field of nuclear medicine, specializing in radiopharmaceuticals. The company is focused on the development and supply of innovative products used for the diagnosis and treatment of various diseases. Operations are conducted across multiple sectors within healthcare, with solutions provided to over 35,000 patients daily. A diverse portfolio including generators, cold kits, and hot products is maintained, ensuring high-quality care through a network spanning over 70 countries. Commitment to safety and reliability is emphasized in every aspect of production and delivery.
Curium Pharma offers Radiopharmaceuticals, Generators, Cold Kits, and Hot Products.
Curium Pharma has made 4 acquisitions, including Cyclopharma, Monrol, and NUCLEIS.
Curium Pharma has 1 investor. Key investors include CapVest.
Curium Pharma operates through Curium Bidco Sarl.